Evaluation of species distribution and risk factors of candidemia: A multicenter case-control study

References

• Richardson MD. Changing patterns and trends in systemic fungal infections. J Antimicrob Chemother 2005; 56(Suppl. S1): i5–i11.
   Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133–163.
   PubMed Web of Science ®Google Scholar
• Pappas PG. Invasive candidiasis. Infect Dis Clin N Am 2006; 20: 485–506.
   PubMed Web of Science ®Google Scholar
• Bassetti M, Trecarichi EM, Righi E, . Incidence, risk factors, and predictors of outcome of candidemia. Survey in 2 Italian university hospitals. Diag Microbiol Inf Dis 2007; 58: 325–331.
   PubMed Web of Science ®Google Scholar
• Inan D, Saba R, Yalcin AN, Yilmaz M, Ongut G. Device-associated nosocomial infection rates in Turkish medical-surgical intensive care units. Infect Control Hosp Epidemiol 2006; 27: 343–348.
   PubMed Web of Science ®Google Scholar
• Lass-Flörl C. The changing face of epidemiology of invasive fungal disease in Europe. Mycoses 2009; 52: 197–205.
   PubMed Web of Science ®Google Scholar
• Yapar N, Uysal U, Yucesoy M, Cakir N, Yuce A. Nosocomial bloodstream infections associated with Candida species in a Turkish university hospital. Mycoses 2006; 49: 134–138.
   PubMed Web of Science ®Google Scholar
• Richardson M, Lass-Flörl C. Changing epidemiology of systemic fungal infections. Clin Microbiol Infect 2008; 14(Suppl. 4): 5–24.
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ, Rinaldi MG, . Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing. J Clin Microbiol 2005; 43: 5848–5859.
   PubMed Web of Science ®Google Scholar
• De Pauw B, Walsh TJ, Donnely JP, . Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis 2008; 46: 1813–1821.
   PubMed Web of Science ®Google Scholar
• Oken MM, Creech RH, Tormey DC, . Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 1982; 5: 649–655.
   PubMed Web of Science ®Google Scholar
• Abi-Said D, Anaissie E, Uzun O, . The epidemiology of hematogenous candidiasis caused by different Candida species. Clin Infect Dis 1997; 24: 1122–1128.
   PubMed Web of Science ®Google Scholar
• Tortorano AM, Peman J, Bernhardt H, . Epidemiology of candidaemia in Europe: results of 28-month European Confederation of Medical Mycology (ECMM) hospital-based surveillance study. Eur J Clin Microbiol Infect Dis 2004; 23: 317–322.
   PubMed Web of Science ®Google Scholar
• Tortorano AM, Kibbler C, Peman J, . Candidaemia in Europe: epidemiology and resistance. Int J Antimicrob Agents 2006; 27: 359–366.
   PubMed Web of Science ®Google Scholar
• Colombo AL, Guimaraes T, Silva LRBF, . Prospective observational study of candidemia in Sao Paulo, Brazil: incidence rate, epidemiology, and predictors of mortality. Infect Control Hosp Epidemiol 2007; 28: 570–576.
   PubMed Web of Science ®Google Scholar
• Anunnatsiri S, Chetchotisakd P, Mootsikapun P. Fungemia in non-HIV-infected patients: a five-year review. Int J Infect Dis 2009; 13: 90–96.
   PubMed Web of Science ®Google Scholar
• Xess I, Jain N, Hasan F, Mandal P, Banarjee U. Epidemiology of candidemia in a tertiary care centre of north India: 5-year study. Infection 2007; 35: 256–259.
   PubMed Web of Science ®Google Scholar
• Passos SX, Costa CR, Araujo CR, . Species distribution and antifungal susceptibility patterns of Candida spp. bloodstream isolates from a Brazilian tertiary care hospital. Mycopathologia 2007; 163: 145–151.
   PubMed Web of Science ®Google Scholar
• Comert F, Kulah C, Aktas E, Eroglu O, Ozlu N. Identification of Candida species isolated from patients in intensive care unit and in vitro susceptibility to fluconazole for a 3-tear period. Mycoses 2006; 50: 52–57.
   Web of Science ®Google Scholar
• Bakir M, Cerikcioglu N, Barton R, Yagci A. Epidemiology of candidemia in a Turkish tertiary care hospital. APMIS 2006; 114: 601–610.
   PubMed Web of Science ®Google Scholar
• Guery BP, Arendrup MC, Auzinger G, . Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: Part I. Epidemiology and diagnosis. Intensive Care Med 2009; 35: 55–62.
   PubMed Web of Science ®Google Scholar
• Ostorsky-Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Crit Care Med 2006; 34: 857–862.
   PubMed Web of Science ®Google Scholar
• Bouza E, Munoz P. Epidemiology of candidemia in intensive care units. Int J Antimicrob Agents 2008; 32(Suppl. 2): S87–S91.
   Google Scholar
• Dimopoulos G, Ntziora F, Rachiotis G, Armaganidis A, Falagas ME. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: Differences in risk factors and outcome. Anesth Analg 2008; 106: 523–529.
   PubMed Web of Science ®Google Scholar
• Chow JK, Golan Y, Ruthazer R, . Factors associated with candidemia caused by non-albicansCandida species versus Candida albicans in the intensive care unit. Clin Infect Dis 2008; 46: 1206–1213.
   PubMed Web of Science ®Google Scholar
• Playford GE, Marriott D, Nguyen Q, . Candidemia in nonneutropenic critically ill patients: risk factors for non-albicansCandida spp. Crit Care Med 2008; 36: 2034–2039.
   PubMed Web of Science ®Google Scholar